Opioid Rx Half a dozen complaints have been filed in Delaware in the past two months, seeking court approval to block coverage of everything from cash damages to attorneys fees. (Photo: Shutterstock)

(Bloomberg) –A multibillion-dollar bill is coming due for the U.S. opioid epidemic and insurers for some of the largest drug makers, distributors and pharmacies are refusing to help pay for it.

A Delaware Supreme Court ruling in January has emboldened insurers eager to avoid massive policy claims from companies proposing to settle liability lawsuits over opioids. Half a dozen complaints have been filed in Delaware in the past two months, seeking court approval to block coverage of everything from cash damages to attorneys fees for companies including CVS Health Corp. and AmerisourceBergen Corp.

 

BenefitsPRO

Join BenefitsPRO

Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join BenefitsPRO.com now!

  • Unlimited access to BenefitsPRO.com - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
  • Exclusive discounts on BenefitsPRO.com and ALM events.

Already have an account? Sign In Now
Join BenefitsPRO

Copyright © 2022 ALM Global, LLC. All Rights Reserved.